Avantor, Inc. $AVTR Shares Sold by Veracity Capital LLC

Veracity Capital LLC lessened its stake in Avantor, Inc. (NYSE:AVTR) by 61.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,580 shares of the company’s stock after selling 53,011 shares during the period. Veracity Capital LLC’s holdings in Avantor were worth $407,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Rise Advisors LLC acquired a new stake in Avantor in the 1st quarter worth about $25,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Avantor by 288.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock valued at $28,000 after purchasing an additional 1,263 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after buying an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in Avantor in the second quarter valued at $32,000. Finally, FNY Investment Advisers LLC acquired a new position in Avantor in the second quarter valued at about $36,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on AVTR shares. Bank of America downgraded Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price for the company. in a research report on Monday. Barclays restated an “equal weight” rating and set a $12.00 target price (down previously from $15.00) on shares of Avantor in a research note on Thursday, October 30th. Evercore ISI dropped their price objective on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Thursday, October 30th. UBS Group set a $12.00 target price on shares of Avantor in a report on Thursday, October 30th. Finally, Jefferies Financial Group downgraded Avantor to an “underperform” rating in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $13.97.

Avantor Stock Performance

Shares of NYSE:AVTR opened at $11.07 on Friday. Avantor, Inc. has a 12 month low of $10.62 and a 12 month high of $23.32. The business has a 50-day moving average of $12.25 and a two-hundred day moving average of $12.79. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.49 and a quick ratio of 0.96. The firm has a market capitalization of $7.55 billion, a PE ratio of -85.15, a P/E/G ratio of 3.82 and a beta of 0.93.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.01). The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm’s revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. As a group, research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insiders Place Their Bets

In other Avantor news, Director Sanjeev K. Mehra bought 350,000 shares of the firm’s stock in a transaction that occurred on Friday, December 5th. The stock was purchased at an average price of $11.09 per share, for a total transaction of $3,881,500.00. Following the purchase, the director directly owned 350,000 shares in the company, valued at $3,881,500. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gregory L. Summe acquired 100,000 shares of the company’s stock in a transaction dated Thursday, October 30th. The stock was acquired at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the purchase, the director owned 300,000 shares in the company, valued at approximately $3,375,000. This represents a 50.00% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 1.20% of the company’s stock.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.